Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
Open Access
- 1 September 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (9) , 1727-1736
- https://doi.org/10.1038/mt.2011.88
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein DClinical and Vaccine Immunology, 2010
- Targeting inhibitory pathways in cancer immunotherapyCurrent Opinion in Immunology, 2010
- Regulatory T Cells in CancerPublished by Elsevier ,2010
- Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”Human Gene Therapy, 2009
- New Insights on Adenovirus as Vaccine VectorsMolecular Therapy, 2009
- Adoptive cell therapy for the treatment of patients with metastatic melanomaCurrent Opinion in Immunology, 2009
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumorsVaccine, 2008
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003